Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 87 descriptions
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 0 mg Prednisone (Rayos (TN)) | [1] Prednisone Prednisone (Rayos) | [1] Prednisone
Prednisone
(Rayos (TN)) 💬1. 0 mg Prednisone
| [1] NR3C1 NR3C1 💬1. 0 mg Prednisone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 44 44 💬1. 0 mg Prednisone
| ||||||||||||||||||||||
2 | 5 mg Prednisone (Rayos (TN)) | [1] Prednisone Prednisone (Rayos) | [1] Prednisone
Prednisone
(Rayos (TN)) 💬2. 5 mg Prednisone
| [1] NR3C1 NR3C1 💬2. 5 mg Prednisone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 44 44 💬2. 5 mg Prednisone
| ||||||||||||||||||||||
3 | Adalimumab, plus prednisone (Rayos (TN)) | [2] Adalimumab Adalimumab,Prednisone (Rayos) | [2] Prednisone
Prednisone
(Rayos (TN)),Adalimumab 💬 3. Adalimumab, plus prednisone
| [2] NR3C1 NR3C1,TNF 💬 | [68] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 [68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African ... | [1] 46 46 💬3. Adalimumab, plus prednisone
| ||||||||||||||||||||||
4 | Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil (Rayos (TN)) | [4] Methylprednisolone Methylprednisolone,Mycophenolate mofetil, Mycophenolic acid, Prednisone (Rayos) | [4] Methylprednisolone
Methylprednisolone
,Prednisone (Rayos (TN)), Mycophenolate mofetil , Mycophenolic acid 💬 [4] Methylprednisolone , Prednisone (Rayos(TN)), Mycophenolate mofetil , Mycophenolic acid ... 4. Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil
| [3] IMPDH1 IMPDH1,IMPDH2, NR3C1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬 [5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nu ... | [1] 49 49 💬4. Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil
| ||||||||||||||||||||||
5 | Azathioprine/prednisone (Rayos (TN)) | [2] Azathioprine Azathioprine,Prednisone (Rayos) | [2] Azathioprine
Azathioprine
,Prednisone (Rayos (TN)) 💬 5. Azathioprine/prednisone
| [1] NR3C1 NR3C1 💬5. Azathioprine/prednisone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 85 85 💬5. Azathioprine/prednisone
| ||||||||||||||||||||||
6 | Capsule di prednisone (Rayos (TN)) | [1] Prednisone Prednisone (Rayos) | [1] Prednisone
Prednisone
(Rayos (TN)) 💬6. Capsule di prednisone
| [1] NR3C1 NR3C1 💬6. Capsule di prednisone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬6. Capsule di prednisone
| ||||||||||||||||||||||
7 | Chinese Herb Prescription Granule plus prednisone (Rayos (TN)) | [1] Prednisone Prednisone (Rayos) | [1] Prednisone
Prednisone
(Rayos (TN)) 💬7. Chinese Herb Prescription Granule plus prednisone
| [1] NR3C1 NR3C1 💬7. Chinese Herb Prescription Granule plus prednisone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬7. Chinese Herb Prescription Granule plus prednisone
| ||||||||||||||||||||||
8 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) (Rayos (TN)) Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, predn ... | [7] Acetate Acetate,Cortisone, Cortisone acetate, Dexamethasone, Hydrocortisone, Prednisolone, Prednisone (Rayos) | [6] Hydrocortisone
Hydrocortisone
,Dexamethasone , Prednisolone , Prednisone (Rayos (TN)), Cortisone acetate , Cortisone 💬 [6] Hydrocortisone , Dexamethasone , Prednisolone , Prednisone (Rayos(TN)), Cortisone acet ... 8. Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
| [1] NR3C1 NR3C1 💬8. Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬8. Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
| ||||||||||||||||||||||
9 | Corticosteroids (prednisone or prednisolone) (Rayos (TN)) | [2] Prednisolone Prednisolone,Prednisone (Rayos) | [2] Prednisolone
Prednisolone
,Prednisone (Rayos (TN)) 💬 9. Corticosteroids (prednisone or prednisolone)
| [1] NR3C1 NR3C1 💬9. Corticosteroids (prednisone or prednisolone)
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬9. Corticosteroids (prednisone or prednisolone)
| ||||||||||||||||||||||
10 | Cyclophosphamide, Azathioprine,prednisone,methylprednisolone (Rayos (TN)) | [4] Azathioprine Azathioprine,Cyclophosphamide, Methylprednisolone, Prednisone (Rayos) | [5] Azathioprine
Azathioprine
,Cyclophosphamide , Methylprednisolone , Prednisone (Rayos (TN)), Cyclophosphamide 💬 [5] Azathioprine , Cyclophosphamide , Methylprednisolone , Prednisone (Rayos(TN)), Cycloph ... 10. Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
| [1] NR3C1 NR3C1 💬10. Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 💬
|